Literature DB >> 11937493

Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18.

Zhonghao Liu1, Jingsong Xu, Jennifer S Colvin, David M Ornitz.   

Abstract

Gain of function mutations in fibroblast growth factor (FGF) receptors cause chondrodysplasia and craniosynostosis syndromes. The ligands interacting with FGF receptors (FGFRs) in developing bone have remained elusive, and the mechanisms by which FGF signaling regulates endochondral, periosteal, and intramembranous bone growth are not known. Here we show that Fgf18 is expressed in the perichondrium and that mice homozygous for a targeted disruption of Fgf18 exhibit a growth plate phenotype similar to that observed in mice lacking Fgfr3 and an ossification defect at sites that express Fgfr2. Mice lacking either Fgf18 or Fgfr3 exhibited expanded zones of proliferating and hypertrophic chondrocytes and increased chondrocyte proliferation, differentiation, and Indian hedgehog signaling. These data suggest that FGF18 acts as a physiological ligand for FGFR3. In addition, mice lacking Fgf18 display delayed ossification and decreased expression of osteogenic markers, phenotypes not seen in mice lacking Fgfr3. These data demonstrate that FGF18 signals through another FGFR to regulate osteoblast growth. Signaling to multiple FGFRs positions FGF18 to coordinate chondrogenesis in the growth plate with osteogenesis in cortical and trabecular bone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11937493      PMCID: PMC186326          DOI: 10.1101/gad.965602

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  57 in total

1.  Receptor specificity of the fibroblast growth factor family.

Authors:  D M Ornitz; J Xu; J S Colvin; D G McEwen; C A MacArthur; F Coulier; G Gao; M Goldfarb
Journal:  J Biol Chem       Date:  1996-06-21       Impact factor: 5.157

2.  Basic fibroblast growth factor: an autocrine growth factor for epiphyseal growth plate chondrocytes.

Authors:  Y Luan; C A Praul; C V Gay; R M Leach
Journal:  J Cell Biochem       Date:  1996-09-01       Impact factor: 4.429

3.  Dual roles for patched in sequestering and transducing Hedgehog.

Authors:  Y Chen; G Struhl
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

Review 4.  Fibroblast-growth-factor receptor mutations in human skeletal disorders.

Authors:  M Muenke; U Schell
Journal:  Trends Genet       Date:  1995-08       Impact factor: 11.639

Review 5.  Toward a molecular understanding of skeletal development.

Authors:  A Erlebacher; E H Filvaroff; S E Gitelman; R Derynck
Journal:  Cell       Date:  1995-02-10       Impact factor: 41.582

6.  Isolation and localization of basic fibroblast growth factor-immunoreactive substance in the epiphyseal growth plate.

Authors:  W O Twal; R Vasilatos-Younken; C V Gay; R M Leach
Journal:  J Bone Miner Res       Date:  1994-11       Impact factor: 6.741

7.  Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein.

Authors:  A Vortkamp; K Lee; B Lanske; G V Segre; H M Kronenberg; C J Tabin
Journal:  Science       Date:  1996-08-02       Impact factor: 47.728

8.  PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth.

Authors:  B Lanske; A C Karaplis; K Lee; A Luz; A Vortkamp; A Pirro; M Karperien; L H Defize; C Ho; R C Mulligan; A B Abou-Samra; H Jüppner; G V Segre; H M Kronenberg
Journal:  Science       Date:  1996-08-02       Impact factor: 47.728

9.  Inhibition of terminal chondrocyte differentiation by bone morphogenetic protein 7 (OP-1) in vitro depends on the periarticular region but is independent of parathyroid hormone-related peptide.

Authors:  A Haaijman; M Karperien; B Lanske; J Hendriks; C W Löwik; A L Bronckers; E H Burger
Journal:  Bone       Date:  1999-10       Impact factor: 4.398

10.  Fibroblast growth factor receptor 3 is a negative regulator of bone growth.

Authors:  C Deng; A Wynshaw-Boris; F Zhou; A Kuo; P Leder
Journal:  Cell       Date:  1996-03-22       Impact factor: 41.582

View more
  154 in total

Review 1.  Fibroblast growth factor receptor 3 mutations in achondroplasia and related forms of dwarfism.

Authors:  William A Horton; Gregory P Lunstrum
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

Review 2.  Genetic disorders of the skeleton: a developmental approach.

Authors:  Uwe Kornak; Stefan Mundlos
Journal:  Am J Hum Genet       Date:  2003-07-31       Impact factor: 11.025

Review 3.  Non-surgical management of early knee osteoarthritis.

Authors:  Elizaveta Kon; Giuseppe Filardo; Matej Drobnic; Henning Madry; Mislav Jelic; Niek van Dijk; Stefano Della Villa
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-10-25       Impact factor: 4.342

Review 4.  Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias.

Authors:  Silvie Foldynova-Trantirkova; William R Wilcox; Pavel Krejci
Journal:  Hum Mutat       Date:  2011-11-16       Impact factor: 4.878

Review 5.  Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease.

Authors:  Nobuyuki Itoh; David M Ornitz
Journal:  J Biochem       Date:  2010-10-12       Impact factor: 3.387

6.  Heparan sulfate-dependent signaling of fibroblast growth factor 18 by chondrocyte-derived perlecan.

Authors:  Christine Y Chuang; Megan S Lord; James Melrose; Martin D Rees; Sarah M Knox; Craig Freeman; Renato V Iozzo; John M Whitelock
Journal:  Biochemistry       Date:  2010-07-06       Impact factor: 3.162

Review 7.  Regulation of Long Bone Growth in Vertebrates; It Is Time to Catch Up.

Authors:  Alberto Roselló-Díez; Alexandra L Joyner
Journal:  Endocr Rev       Date:  2015-10-20       Impact factor: 19.871

8.  Fibroblast growth factor expression during skeletal fracture healing in mice.

Authors:  Gregory J Schmid; Chikashi Kobayashi; Linda J Sandell; David M Ornitz
Journal:  Dev Dyn       Date:  2009-03       Impact factor: 3.780

Review 9.  Role of perlecan in skeletal development and diseases.

Authors:  John Hassell; Yoshihiko Yamada; Eri Arikawa-Hirasawa
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

10.  Knockdown of the pericellular matrix molecule perlecan lowers in situ cell and matrix stiffness in developing cartilage.

Authors:  Xin Xu; Zhiyu Li; Yue Leng; Corey P Neu; Sarah Calve
Journal:  Dev Biol       Date:  2016-08-27       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.